No Pharma Money
All News & Reports

News

The week in prescription drug pricing: what moved, what it means for patients, and what comes next.

Stay Up To Date

News and reports from P4ADNow

News Apr 5, 2024

This Week in Prescription Drug Pricing: Patient advocate introduces POTUS, P4AD launches new tool to defend Medicare negotiations, and how the Inflation Reduction Act is lowering drug costs for women

Kris Garcia, a husband, father of four, and a P4AD patient advocate from Colorado introduced the President at the White House on Wednesday during an event hosted by President Biden and Senator…

Read Article
News Mar 29, 2024

This Week in Prescription Drug Pricing: Lowering drug costs for patients, Teva hindering generic competition, and surging pharma CEO compensation

On Tuesday, the Department of Health & Human Services (HHS) announced a list of 41 drugs available through Medicare Part B will have a lower coinsurance rate from April 1 – June 30, 2024, should drug…

Read Article
News Mar 22, 2024

This Week in Prescription Drug Pricing: Big Pharma caught in contradiction, the growing impact of the Inflation Reduction Act, and the power of public pressure

Big drug companies continue to drum up bold lies regarding the impact of the drug price reforms in the Inflation Reduction Act (IRA).

Read Article
News Mar 15, 2024

This Week in Prescription Drug Pricing: PBM reform picks up momentum, Big Pharma lies exposed, and the legal fight over Medicare negotiation

Key Senators remain committed to advancing bipartisan bills aimed at cracking down on pharmacy benefit managers (PBMs) and their opaque tactics, which drive up costs for patients and taxpayers.

Read Article
News Mar 11, 2024

This Week in Prescription Drug Pricing: Boehringer Ingelheim caps Inhaler costs due to public pressure, Biden’s SOTU emphasized drug price reforms, and oral arguments heard in 4 cases against Medicare negotiation

In a week marked by significant developments in the fight to make medicine more affordable, Patients For Affordable Drugs Now (P4ADNow) applauded President Biden’s ongoing commitment to reducing drug…

Read Article
News Mar 2, 2024

This Week in Prescription Drug Pricing: AstraZeneca’s courtroom rejection, legislators show support for Medicare negotiation, and a new study on the high cost of insulin.

Yesterday, a federal judge in Delaware delivered a significant blow to AstraZeneca by ruling against the company in its effort to halt the negotiation of its diabetes drug, Farxiga, marking a pivotal…

Read Article
News Feb 23, 2024

The Week in Review in Prescription Drug Pricing

It’s been 18 months since the passage of the Inflation Reduction Act and we’re still buzzing about the drug price reforms that are helping millions of patients see cost savings.

Read Article
News Feb 16, 2024

The Week in Review in Prescription Drug Pricing

Marking an important step in protecting Medicare’s ability to negotiate lower prices for millions of patients, a Texas federal judge dismissed the lawsuit from trade association Pharmaceutical…

Read Article
News Feb 9, 2024

The Week in Review in Prescription Drug Pricing

Senators Peter Welch and Amy Klobuchar were joined by patient advocates and health care experts for a panel discussion on Big Pharma’s use of patent thickets to extend market exclusivity and the new…

Read Article
News Feb 2, 2024

The Week in Review in Prescription Drug Pricing

As part of the sweeping reforms to lower prescription drug costs for millions of patients, the Centers For Medicare and Medicaid Services (CMS) sent initial price offers to drug manufacturers for the…

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.